Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2020-09-11
Product name
ELTROMBOPAG POWDER FOR ORAL SUSPENSION SACHET
Product Synonyms
ELTROMBOPAG 20MG SACHET * ELTROMBOPAG 25MG SACHET *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Combustible dusts Category 1
Health hazards
Serious eye damage/eye irritation Category 2A Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 2
Hazard pictograms
None.
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air.
Prevention
Prevent dust accumulation to minimize explosion hazard. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep container tightly closed. Ground and bond container and receiving equipment.
Response
Take off contaminated clothing and wash it before reuse. In case of fire: Use appropriate media to extinguish.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Assume that this material is capable of sustaining combustion. Assume that this material is capable of being ignited by an electrostatic discharge. Assume that this material is capable of producing a dust explosion if ignited as a dust cloud. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
3.96 % of the mixture consists of component(s) of unknown acute dermal toxicity. 3.96 % of the mixture consists of component(s) of unknown acute inhalation toxicity.
